Ensysce Biosciences Inc Ordinary Shares ENSC 深 滬
已收盤 07-25 16:00:00 美东时间
2.24
+0.040
+1.82%
華盛通- 最 高2.36
- 今 開2.20
- 成交量 10.13万股
- 最 低 2.1766
- 昨 收 2.20
- 總市值 531.04万
- 52周最高 14.67
- 市盈率 靜 --
- 換手率 4.27%
- 52周最低 1.62
- 委 比 -9.70%
- 總股本 237.07万
- 歷史最高 61632.00
- 量 比 1.61
- 振 幅 8.34%
- 歷史最低 1.62
- 每 手 1
- 風險率 2.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ensysce Biosciences Launches Phase 3 Trial For Abuse-Resistant Painkiller PF614, Selects Rho, Inc. As Clinical Partner
~ FDA Protocol Review Completed ~~ Rho, Inc. Selected as Clinical Research Partner ~SAN DIEGO, CA / ACCESS Newswire / July 16, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage
07-16 20:05
Ensysce Biosciences Says It Fully Enrolled Part 2 Of Critical Three-Part PF614-MPAR-102 Clinical Study To Study Effect Of Food On MPAR Technology
~ Treatment to Evaluate Effect of Food on Overdose Protection of MPAR ~~ Grant Funds from NIDA Accelerating Clinical Development Program ~SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 24, 2025 / Ensysce Biosciences,
06-24 20:11
Ensysce Biosciences Secures $5.3M In Continued NIDA Support To Advance Opioid Overdose Protection
~ PF614-MPAR Moving to Next Stage of Development, Finalizing Drug Formulation ~~ Funds Accelerate Path Towards Commercialization ~
06-04 20:13
Ensysce Biosciences Q1 EPS $(1.39) Beats $(3.02) Estimate, Sales $1.32M Up From $305.72K YoY
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(1.39) per share which beat the analyst consensus estimate of $(3.02) by 53.97 percent. This is a 83.07 percent increase over losses of $(8.21) per share
05-14 04:39
Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds
Ensysce Biosciences (NASDAQ:ENSC) has entered a definitive agreements for the immediate exercise of certain outstanding warrants for gross proceeds of around $2.2M. ENSC -21.52% after hours to $2.88. ...
04-24 05:13
Ensysce Biosciences Advances in Opioid Innovation
Ensysce Biosciences, Inc. ( ($ENSC) ) has released its Q4 earnings. Here is a b...
03-20 11:57
Ensysce Biosciences Regains Full Nasdaq Compliance
Meeting Minimum Bid Price And Stockholders' Equity Requirements; Common Stock To Continue Trading On Nasdaq Capital Market
2024-12-23 21:21
Ensysce Biosciences Q3 2024 GAAP EPS $0.07 Beats $(0.29) Estimate, Sales $3.40M Beat $250.00K Estimate
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.29) by 124.14 percent. The company reported quarterly sales of $3.40 million which beat
2024-11-13 05:37
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Carvana Co. (NYSE:CVNA) rose in today's pre-market trading after the ...
2024-10-31 18:52
Ensysce Biosciences receives non-compliance notice from Nasdaq
Ensysce Biosciences (NASDAQ:ENSC) said on Friday that it has received notice from the Nasdaq’s listing qualifications department stating that the company has not regained compliance with its listing r...
2024-09-28 04:57
